This inventor holds 2 USPTO granted patents, plus 4 CIPO patents. Top assignee: Mayo Foundation for Medical Education and Research. Active years: 1999-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999-2001
Title: Patrick C Roche - Innovator in Antibody Development.
Introduction
Patrick C Roche is a notable inventor based in the United States. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work focuses on innovative solutions that address critical health challenges.
Latest Patents
Patrick C Roche holds a patent titled "Anti-Pd-L1 Antibodies And Diagnostic Uses Thereof." This invention provides programmed death-ligand 1 (PD-L1) antibodies and methods of using the same. Although he currently has 2 patents, his research has the potential to impact cancer treatment and diagnostics significantly.
Career Highlights
Throughout his career, Patrick has demonstrated a commitment to advancing medical science. His research has contributed to a deeper understanding of immune responses and therapeutic interventions. His work is recognized for its potential to improve patient outcomes in oncology.
Collaborations
Patrick has collaborated with Zhiming Liao, a fellow researcher, to enhance the development of PD-L1 antibodies. Their partnership exemplifies the importance of teamwork in scientific research and innovation.
Conclusion
In summary, Patrick C Roche is an influential inventor in the field of antibody development. His work on PD-L1 antibodies showcases his dedication to advancing medical science and improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile